These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31239156)

  • 1. Oncological outcome following initiation of treatment for stage III and IV HPV negative oropharyngeal cancers with transoral robotic surgery (TORS).
    Dabas S; Gupta K; Sharma AK; Shukla H; Ranjan R; Sharma DK
    Eur J Surg Oncol; 2019 Nov; 45(11):2137-2142. PubMed ID: 31239156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial.
    Dabas S; Gupta K; Ranjan R; Sharma AK; Shukla H; Dinesh A
    Oral Oncol; 2017 Jun; 69():80-83. PubMed ID: 28559025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
    Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
    Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma-A large observational single-centre series from the United Kingdom.
    O'Hara J; Warner L; Fox H; Hamilton D; Meikle D; Counter P; Robson A; Goranova R; Iqbal S; Kelly C; Robinson M; Paleri V
    Clin Otolaryngol; 2021 Sep; 46(5):1005-1012. PubMed ID: 33754476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and survival outcomes in elderly patients undergoing transoral robotic surgery.
    Philips R; Topf MC; Crawley MB; Swendseid B; Luginbuhl A; Curry J; Cognetti D
    Oral Oncol; 2020 Dec; 111():104954. PubMed ID: 32827931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transoral robotic surgery for squamous cell carcinoma of the oropharynx in a primarily human papillomavirus-negative patient population.
    Viros Porcuna D; Pollan Guisasola C; Viña Soria C; Cirauqui Cirauqui B; Pardo Muñoz L; Collurá F; Mesia Nin R
    Clin Transl Oncol; 2020 Aug; 22(8):1303-1311. PubMed ID: 31858433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma.
    Sievert M; Goncalves M; Zbidat A; Traxdorf M; Mueller SK; Iro H; Gostian AO
    Auris Nasus Larynx; 2021 Apr; 48(2):295-301. PubMed ID: 32883577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinoma.
    Park YM; Kim HR; Cho BC; Keum KC; Cho NH; Kim SH
    Oral Oncol; 2017 Dec; 75():16-21. PubMed ID: 29224814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of transoral robotic surgery in treatment of oropharyngeal squamous cell carcinoma].
    Zhang X; Chen SW; Yang ZY; Chen JT; Su X; Yang AK; Song M
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 May; 57(5):545-551. PubMed ID: 35610671
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients With Early-Stage Oropharyngeal Squamous Cell Carcinoma.
    Nguyen AT; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Shiao SL; Ho AS; Zumsteg ZS
    JAMA Oncol; 2020 Oct; 6(10):1555-1562. PubMed ID: 32816023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical value of oral robotic surgery in the treatment of oropharyngeal squamous cell carcinoma].
    Zhang X; Yang ZY; Yang AK; Zhang Q; Li QL; Chen SW; Chen JT; Song M
    Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):570-576. PubMed ID: 35754232
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
    Smith RV; Schiff BA; Garg M; Haigentz M
    Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological outcomes of early glottic carcinoma treated with transoral robotic surgery.
    Kayhan FT; Koc AK; Erdim I
    Auris Nasus Larynx; 2019 Apr; 46(2):285-293. PubMed ID: 30217617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
    Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
    Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma.
    Lörincz BB; Möckelmann N; Busch CJ; Knecht R
    Head Neck; 2015 Nov; 37(11):1618-24. PubMed ID: 24955923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
    Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan.
    Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N
    Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of oncological outcomes between transoral surgical and non-surgical treatment protocols in the management of oropharyngeal squamous cell carcinoma.
    Kao SS; Micklem J; Ofo E; Edwards S; Dhatrak D; Foreman A; Krishnan S; Hodge JC
    J Laryngol Otol; 2018 Apr; 132(4):349-355. PubMed ID: 28480836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.
    Carey RM; Brody RM; Shimunov D; Shinn JR; Mady LJ; Rajasekaran K; Cannady SB; Lin A; Lukens JN; Bauml JM; Cohen RB; Basu D; O'Malley BW; Weinstein GS; Newman JG
    Laryngoscope; 2021 Dec; 131(12):E2865-E2873. PubMed ID: 34076275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.